Torvacard 10-20mg 30 tablets

Torvacard Composition:
active ingredient: atorvastatin (in the form of atorvastatin calcium trihydrate);
1 tablet contains atorvastatin 10 mg (equivalent to atorvastatin calcium trihydrate 10.823 mg);
excipients: calcium carbonate, microcrystalline cellulose, lactose monohydrate, low-substituted hydroxypropyl cellulose, povidone K12, anhydrous colloidal silicon dioxide, magnesium stearate; film shell: hypromelose, polyethylene glycol 6000, titanium dioxide (E 171), talc, iron oxide yellow (E 172), lactose monohydrate.

Indications

     – Reduce the risk of myocardial infarction;
     – Reducing the risk of stroke;
     – Reducing the risk of revascularization procedures and angina.
For patients with type II diabetes and no clinically significant coronary heart disease but with multiple risk factors for coronary heart disease such as retinopathy, albuminuria, smoking or hypertension, atorvastatin is indicated for:
     – Reduce the risk of myocardial infarction;
     – Reducing the risk of stroke.
For patients with clinical coronary heart disease, atorvastatin is indicated for:
     – Reducing the risk of non-lethal myocardial infarction;
     – Reduce the risk of lethal and non-lethal stroke;
     – Reducing the risk of revascularization procedures;
     – Reducing the risk of hospitalization due to congestive heart failure;
     – Reducing the risk of strokes.

Contraindications

– Active liver disease, which may include a persistent increase in liver enzymes of unknown etiology.
– Hypersensitivity to any component of this medication.

Dosage & Administration

Hyperlipidemia (heterozygous familial and non-family) and mixed dyslipidemia (type IIa and IIb Fredrickson classification).
The recommended starting dose of atorvastatin is 10 or 20 mg 1 time a day.

For patients requiring a significant reduction in LDL-C (over 45%), therapy may be initiated dosing of 40 mg 1 time a day. Atorvastatin dose range is between 10 to 80 mg 1 time a day. The drug can make a one-time dose at any hour and regardless of the meal. Initial and maintenance doses of atorvastatin should be individualized depending on the purpose of treatment and response.

After the treatment and / or upon titration of the dose of atorvastatin should be analyzed lipid levels over a period of 2 to 4 weeks and dosage adjusted accordingly.

Heterozygous familial hypercholesterolemia in pediatric patients (aged 10-17 years).
The recommended starting dose of atorvastatin is 10 mg / day; The maximum recommended dose – 20 mg / day (doses exceeding 20 mg in this group of patients not studied).

The dose should be individualized according to the recommended goal of therapy. Dose adjustment should be made at intervals of 4 weeks or more.